This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q94479056
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована 1 травня 2020 im Mai 2020 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en mayu de 2020 scientific article published on 01 May 2020 wetenschappelijk artikel article scientifique publié en 2020
p:P577
wds:Q94479056-397E38E8-9373-4CA4-B790-07ECA092D98F
wdt:P577
2020-05-01T00:00:00Z
p:P2860
wds:Q94479056-FDB63E11-9FC4-4971-90EB-86AD2685CED1 wds:Q94479056-DADBBCB2-EEE9-4AE9-A172-EA6A7D4F212C wds:Q94479056-DBFBDAEE-3C36-4D39-98F4-45C2A2AD23E3 wds:Q94479056-DBFC7A13-CB95-4266-9CAE-02D05D8108AF wds:Q94479056-D988F120-A856-4696-BD95-15F5CC4561B2 wds:Q94479056-B493471D-F1C1-40FC-8BC6-FED405190C6A wds:Q94479056-BCBBE8A1-F5A0-4BF1-9309-B20F1F0A8332 wds:Q94479056-8D901CE0-3060-4F56-B7FE-5E2180E10C96 wds:Q94479056-95CD05EA-8F9F-40AB-9E45-1CFB6ED94725 wds:Q94479056-7F9F1683-4121-4D24-BFC0-4D0ED06BBBD0 wds:Q94479056-74AF72EE-D2C5-4098-949F-6ED052F458E1 wds:Q94479056-74EAFD8B-4113-48BB-B5E6-68EA83673F5B wds:Q94479056-78541500-4E5C-43E4-97E5-5C7A38463163 wds:Q94479056-565E454D-05B6-4AF3-BD92-B46F0AD75218 wds:Q94479056-4963704E-550D-4090-BDD8-E8D11F5F01AA wds:Q94479056-5643746C-C0FA-4614-8ED3-B2A81195E3ED wds:Q94479056-2BCBBE3B-5D89-4025-9BD7-06F209FEECBE wds:Q94479056-074CB8AD-B880-4BC3-B8AB-72009907E783 wds:Q94479056-008EEF39-2BB0-4DF7-9284-6B5F35E5B70D
wdt:P2860
wd:Q33406742 wd:Q44841161 wd:Q33393623 wd:Q91700268 wd:Q37273186 wd:Q27824784 wd:Q48792987 wd:Q80282618 wd:Q86867086 wd:Q92247414 wd:Q47788410 wd:Q33391398 wd:Q45899999 wd:Q47582438 wd:Q37526899 wd:Q48826060 wd:Q39685534 wd:Q34621900 wd:Q38642477
p:P2093
wds:Q94479056-D824D293-1F16-449F-8FAF-F03322CFD58F wds:Q94479056-D81E7049-549B-4796-8613-82A65C992246 wds:Q94479056-ED4005B5-BB11-49DA-A8E4-C47367EB7E2D wds:Q94479056-0A26EE36-0B4D-461C-8B77-899E80364D15 wds:Q94479056-0F86ADB5-6020-4F7D-A1CD-BC6F73AB19FB wds:Q94479056-02E293E7-2687-4749-B34F-3726FEB18475 wds:Q94479056-2030A1B8-B79C-4C24-BD65-CCEFC389F23F wds:Q94479056-112E9A85-3A57-45B6-8EE6-20BB61794D64 wds:Q94479056-134A00BC-BEBF-4CFB-AE4A-1A366D11B5AE wds:Q94479056-696F83BD-87E4-432A-8CAE-3D1065BFA167 wds:Q94479056-7202E5E7-F8B3-4916-B0C0-4804761839B5 wds:Q94479056-465BC98A-3592-4973-811D-1AB581C19C33 wds:Q94479056-35536395-8681-4014-A1DE-2202DE4F4947 wds:Q94479056-4E74A139-76CE-4003-AC0E-AAEEEAE73A0F wds:Q94479056-B8EC4A65-6442-41EF-84D6-6C8C232F76D1 wds:Q94479056-B7C11AF3-D34B-4763-95F5-8B150124F3B9 wds:Q94479056-D0BB964B-FF50-450C-8B98-47093517A684 wds:Q94479056-BE93FE71-4181-4F83-B43F-966EC20B5D06 wds:Q94479056-803C4F48-DA89-4A40-AE59-921D0F85583D wds:Q94479056-86BC7E15-B1F7-4D9A-9D29-B79E7460E481 wds:Q94479056-78D73AB4-FD23-48FB-8D5C-10B3C85461F7 wds:Q94479056-A11A3520-40EF-4CB1-8EF6-540A6C4C2DEB wds:Q94479056-A778E88F-BE7E-4586-A999-1B1522C33A31
wdt:P2093
Daniela De Lorenzo Vittoria Tarantino Marco Foppoli Teresa Calimeri Sara Steffanoni Alice Di Rocco Renato Zambello Francesco Zaja Chiara Rusconi Caterina Cecchetti Caterina Stelitano Annalisa Arcari Piera Angelillo Maurizio Frezzato Eloise Scarano Alberto Fabbri Stefano Volpetti Marianna Sassone Salvatore Perrone Maurilio Ponzoni Giovanni Bertoldero Alessandro Nonis Alessandro Re
rdfs:label
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
skos:prefLabel
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
schema:name
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
p:P50
wds:Q94479056-448F6C98-8F78-4D4E-B282-4ACE8DB8C4A8 wds:Q94479056-D6ECEB86-40F0-4CE8-B27D-F4F76D1A8DBD wds:Q94479056-FD827B00-C251-42CB-8743-3731CAD3AB61
wdt:P50
wd:Q53394076 wd:Q88671445 wd:Q90995474
p:P1476
wds:Q94479056-D4D855BD-FBE1-4406-99A0-E327ACC64075
wdt:P1476
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
p:P31
wds:Q94479056-F42CC468-9C32-43AC-9110-C4878F7CFC5D
wdt:P31
wd:Q13442814
p:P921
wds:Q94479056-5F2DA4D0-E0EA-4010-A15D-D12B13B395BB
wdt:P921
wd:Q2626074
p:P698
wds:Q94479056-767BD474-F632-4494-8E38-94C035A9B02F
wdtn:P698
n12:32356913
wdt:P698
32356913
p:P1433
wds:Q94479056-4684DDAF-A3CD-4F19-8EDE-42242189D4DD
wdt:P1433
wd:Q15762617
p:P356
wds:Q94479056-BD4C99E6-5057-424E-82B2-C1CDD8FE8A76
wdtn:P356
n10:HON.2742
wdt:P356
10.1002/HON.2742